Details of the Target
General Information of Target
Probe(s) Labeling This Target
ABPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
OPA-S-S-alkyne Probe Info |
![]() |
K10462(1.27); K12412(1.99); K12623(3.22); K12605(3.80) | LDD3494 | [1] | |
DBIA Probe Info |
![]() |
C13395(1.33) | LDD3312 | [2] | |
Acrolein Probe Info |
![]() |
C14373(0.00); C13395(0.00); C12718(0.00); C13687(0.00) | LDD0222 | [3] | |
W1 Probe Info |
![]() |
K12585(0.88); E12573(0.88); R12574(0.88) | LDD0237 | [4] | |
TFBX Probe Info |
![]() |
C13687, C13219(0.00); C13842, C12282, C12751, C12440, C13531(0.00) | LDD0027 | [5] |
Competitor(s) Related to This Target
Competitor ID | Name | Cell line | Binding Site(Ratio) | Interaction ID | Ref |
---|---|---|---|---|---|
LDCM0108 | Chloroacetamide | HeLa | C14373(0.00); C13395(0.00); C12718(0.00); C13687(0.00) | LDD0222 | [3] |
LDCM0022 | KB02 | A2780 | C13239(1.64); C12718(1.96) | LDD2254 | [2] |
LDCM0023 | KB03 | A2780 | C13239(1.84); C12718(1.68) | LDD2671 | [2] |
LDCM0024 | KB05 | HMCB | C13395(1.33) | LDD3312 | [2] |
LDCM0109 | NEM | HeLa | N.A. | LDD0231 | [3] |
LDCM0110 | W12 | Hep-G2 | K12585(0.88); E12573(0.88); R12574(0.88) | LDD0237 | [4] |
The Interaction Atlas With This Target
The Drug(s) Related To This Target
Approved
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Dimethyl Sulfoxide | . | DB01093 |
Phase 3
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Abagovomab | Monoclonal antibody | D00KGB | |||
Oregovomab | Monoclonal antibody | D07HUW |
Phase 2
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Regn4018 | Antibody | D0LA9K |
Phase 1
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Dmuc-5754a | Antibody | D04ZIZ | |||
Prgn-3005 | CAR T Cell Therapy | D12AIV | |||
Jcar020 | . | D0I0FA |
Discontinued
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Rg7458 | Antibody | D0G9ZJ |
References